Stony Brook University

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Stony Brook University sits in the top decile of US sponsors by registered trial count (#213 of 15,742 sponsors by registered trial count).

127 total trials 24 currently recruiting 81 completed top decile by trial count

Stony Brook University: 127 sponsored US clinical trials, 24 recruiting.

Stony Brook University sponsors 127 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 81 completed. 22 of these trials are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 3 trials.

Top-decile sponsor footprint

Stony Brook University ranks in the top decile of sponsors by registered trial count (#213 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

81 of 95 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

127 total, page 3 of 3

COMPLETED Phase 3

Diabetes and Periodontal Therapy Trial

NCT00997178

COMPLETED NA

Benefit of CoQ-10 in Patients on Statins

NCT00997269

TERMINATED Phase 4

Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention

NCT01464671

COMPLETED Phase 1

Treadmill Training With Lower Extremity Amputees

NCT01419288

COMPLETED

Investigating the Impact of Mode of Administration on Item Response

NCT00783991

COMPLETED NA

Fatigue Self-Management in Primary Care

NCT00997451

TERMINATED Phase 1

IGF-1 Therapy in Patients With Cystic Fibrosis

NCT00566241

COMPLETED Phase 2

Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain

NCT00636454

COMPLETED NA

Heat Versus Ice in the Acute Management of Neck and Back Strain Injuries

NCT01535365

COMPLETED Phase 2

Lidocaine Patches Prior to Intravenous Insertion

NCT00552695

TERMINATED NA

Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery

NCT00790829

COMPLETED NA

Chromium's Effect on Insulin Resistance in Obesity

NCT00997659

COMPLETED Phase 2

Comparison of Suturing and Packing of Drained Abscesses

NCT00465049

COMPLETED Phase 1

Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer

NCT00331786

COMPLETED

HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women

NCT00291044

COMPLETED

Novel Therapy for Glucose Intolerance in HIV Disease

NCT02006914

COMPLETED Phase 1

Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand

NCT00261209

COMPLETED NA

Cardiovascular Risk Factors, Body Composition, Fitness Levels And Quality Of Life In Overweight And Obese 8-17 Year Olds

NCT02024399

COMPLETED Phase 4

Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder

NCT00228046

COMPLETED Phase 2

Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation

NCT00396578

COMPLETED Phase 3

Collagenase in the Treatment of Dupuytrens Disease

NCT00260429

COMPLETED Phase 2

Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial

NCT00790270

COMPLETED Phase 4

Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children

NCT00790075

COMPLETED Phase 1

Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus

NCT00545857

COMPLETED Early Phase 1

Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit

NCT01878643

COMPLETED Phase 1

Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

NCT00004494

COMPLETED Phase 3

Correction of Myopia Evaluation Trial (COMET)

NCT00000113

← Previous Page 3 of 3

What is open in the Stony Brook University pipeline

24 recruiting of 127 indexed (19% open); 81 completed (64%).

Phase mix: 22 late (III/IV) vs 33 early (I/II) (balanced across stages).

Top condition: Healthy (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Stony Brook University: open-pipeline peers nationwide

Peers matched on 127 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Stony Brook University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 10%20%30%40%50% Total trials Recruiting share Stony Brook UniversityJazz PharmaceuticalsThe Methodist Hospital Research InstituteUniversity of Illinois at Urbana-ChampaignMethodist Health SystemIpsenSpaulding Rehabilitation HospitalMedical University of South CarolinaJonsson Comprehensive Cancer Center
Stony Brook University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Stony Brook University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 127 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Stony Brook University page

127 registered trials is a research-attention snapshot, not an endorsement of Stony Brook University or any single study.

  • 24 of Stony Brook University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition Stony Brook University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Stony Brook University pipeline card: 127 registered trials from official public datasets.Report a data error.